Stroke remains the second leading cause of death and the third leading cause of death and
disability combined worldwide, as indicated by disability-adjusted life-years (DALYs) lost [1] …

Background and Purpose—Because several new devices for mechanical thrombectomy
have become available, the outcomes of patients undergoing endovascular treatment for …

Until 1995, treatment of ischemic stroke consisted exclusively of efforts to prevent
recurrence. Since that time, the introduction of recombinant tissue plasminogen activator …

An overwhelming benefit from endovascular treatment of ischaemic stroke could be shown
in recent clinical trials, making it the new evidence-based standard of care for ischaemic …

Stroke is a major contributor to death and disability worldwide. Prior to modern therapy, post-
stroke mortality was approximately 10% in the acute period, with nearly one-half of the …

The emergent endovascular management of patients with acute ischemic stroke (AIS)
caused by a large arterial occlusion (LAO) exploded following the 2015 publication of pivotal …

The ESCAPE trial demonstrated strong morbidity benefit and mortality reduction for
endovascular stroke treatment. Following the release of the main results, the ESCAPE trial …

In 2015, multiple randomized controlled trials clearly demonstrated that mechanical
thrombectomy could save lives and prevent disability in patients with large vessel acute …

Deficits–Intra-Arterial) 9 along with the presentation of SWIFT PRIME (Solitaire With the
Intention for Thrombectomy as Primary Endovascular Treatment Trial) 10 all showing …

Acute ischemic stroke is the primary cause of acquired disability in adults and is the second
leading cause of death worldwide. Following the introduction of intravenous thrombolysis …